Saireitoh is a traditional Chinese medicine that is often given to patients with nephrotic syndrome or glomerulonephritis. Studies have reported that Saireitoh stimulates intrinsic steroid secretion in rats and suppresses the proliferation of fibroblasts in vitro. We examined the effects of Saireitoh on vascular smooth muscle cell proliferation and migration in vitro and experimental atherosclerosis in vivo. Saireitoh rabbit serum obtained from New Zealand White rabbits which were given a diet containing 2% Saireitoh for 3 days significantly inhibited [3H] -thymidine incorporation by smooth muscle cells, which were isolated from thoracic aorta explants of rabbits. The addition of 10% Saireitoh rabbit serum to a culture medium containing smooth muscle cells inhibited DNA synthesis by 50% as compared with a control culture to which 10% normal rabbit serum was added. We also found that the number of smooth muscle cells in the culture containing Saireitoh rabbit serum was decreased. When PDGF was used as a chemoattractant, we demonstrated that Saireitoh rabbit serum slightly inhibits the migration of smooth muscle cells. In in vivo experiments, Saireitoh did not suppress the development of atherosclerosis but tended to reduce the damage. We concluded that although Saireitoh inhibited the proliferation of smooth muscle cells, the effect of prevention on the development of atherosclerosis is weak in the in vivo condition.
Introduction
Atherosclerosis is caused by a complicated and altered interaction between cells such as endothelial cells, smooth muscle cells (SMC), macrophages or lymphocytes and other factors such as cytokines, growth factors and the extra cellular matrix. Examination of the atherosclerotic lesion reveals diffuse changes in the structure of the SMCs and the extra cellular matrix in the intima and media (1) . The extra cellular matrix has also been shown to play an important role in the progression of atherosclerosis (2) . Hypercholesterolemia impairs endothelial function and promotes the interaction between various cells and the vessel wall (3) . The accumulation of cholesterol in the arterial vessel wall is a prominent feature of atherosclerosis. Arterial intimal thickening induced after endothelial denudation by means of a balloon catheter is one of the most commonly used experimental models for a developing atheromatous plaque (4) (5) (6) (7) (8) . Intimal thickening is mainly due to the migration of SMC into the intima and the proliferation of these cells mediated by various inflammatory cytokines and growth factors that have been released by inflammatory cells or synthesized within the arterial wall (9, 10) . Studies have shown that immunological and inflammatory mechanisms play an important role in proliferative arterial disease (11-13).
Saireitoh is a popular Chinese medicine composed of twelve different natural herbs. This preparation, in combination with Goreisan and Shosaikotoh, has been used clinically for nephritis, nephrotic syndrome or hepatic disease (14) . Previous studies have reported that Saireitoh stimulates intrinsic steroid secretion in rats and et al. Histological analysis In the cholesterol fed study, there were fewer foam cells in the intima of the Saireitoh group compared with the control group (Figs. 9a, b) , and there was a tendency for fewer collagen fibers in the intima (Figs. 9c, d ). In the balloon injury study, a hypertrophic neo-intima was observed in both the Saireitoh and control groups (Fig. 10) . The cells in the hypertrophic regions were decreased and the extra cellular matrix was more developed in the Saireitoh group as compared with the control group. The foam cells, the collagen fibers and the elastic fibers in the histological sections were not different between the two groups. These results indicate that Saireitoh suppresses the development of atherosclerosis by inhibiting SMC proliferation in both cholesterol fed and de-endothelial rabbit models.
Discussion
Atherosclerosis is characterized by a restrictive thick- Cell numbers in intimal thickening were also observed. Foam cells are an important feature of early atherosclerotic lesions. They progress to fatty streaks and fibrous plaques which are composed of a complex of cells and extra cellular matrix (17) . In the hypertrophic intima, the SMCs proliferate and the connective tissues expand, which leads to a narrowing of the arteries. This process leads to chronic hypoxia of the tissues being supplied by the damaged artery. The complex interaction between cells and cytokines, growth factors and the extra cellular matrix are important factors in the progression of atherosclerosis (18, 19) .
A number of studies have investigated the various effects or pharmacological actions of Kampo medicine (14) (15) (16) (20) (21) (22) (23) (24) (25) . Kampo medicine is defined as a medicine that consists of many ingredients having various pharmacological actions without specificity for a disease. The same Kampo medicine is often used for different diseases.
Saireitoh is one class of Kampo medicine and is composed of twelve different natural herbs (Table 3) . This medicine is combined with Goreisan and Shosaikotoh and has been widely used in the management of patients with nephritis, nephrotic syndrome or hepatic disease (14). Previous studies have indicated that Saikozai such as Saireitoh or Shosaikotoh enhance the effects of corticoid hormone (20) (21) (22) . Other studies also suggested that Saireitoh enhanced the effects of steroids or completely inhibited any augmentation in platelet aggregation (21) . Using Saireitoh with steroid therapy reduces not only the dose of steroid needed but also reduces the side effects.
Tashiro showed that Saireitoh has antiinflammatory effects and inhibits the movement of fibrob- lasts by modifying the immune system or through' its steroid-like effect (15) . In one study, Saireitoh directly inhibited the growth of fibroblasts in the serum of rabbits given Saireitoh orally. This study also showed that Shosaikotoh, one of the main ingredients in Saireitoh, preserved normal macrophage function in the presence of markedly elevated serum cholesterol, which prevented the development of atherosclerosis (23, 24) . Another study reported that Shosaikotoh induced the release of INF-y by activating monocytes and T lymphocytes (25) .
In this study, we investigated the influence of Saireitoh on SMC proliferation in vitro and on experimental atherosclerosis in New Zealand White rabbits using two different models : the cholesterol fed model and the de-endothelial model. In the in vitro vascular SMC proliferation and migration study, Saireitoh rabbit sera significantly inhibited the dose and time dependent reduction of SMC proliferation and slightly inhibited the migration. In the cholesterol fed model, we evaluated the effect of Saireitoh on experimental atherosclerosis in rabbits fed a highcholesterol diet by calculating the S.I. and A.I. and observing the histological changes microscopically.
In vivo, Saireitoh did not prevent the development of atherosclerosis, but it did not exert a harmful influence on the antiatherogenic action and tended to reduce the damage. The values for S.I. and A.I. were smaller in the Saireitoh group than in the control group, and the intimal thickness, the number of foam cells and the amount of collagen fibers in the intima all tended to be reduced.
In other studies, Saireitoh tends to reduce not only the intima/ media ratio in the histological sections of balloon injured arteries but also the cell numbers in the intima. Histological analysis of the damaged arteries in the cholesterol fed model showed that the degree of intimal thickening formed by hypercholesterolemia tended to decrease in the Saireitoh group through the reduction of foam cells and collagen fibers. The result of these experimental vivo studies did not contradict the outcome of the vitro studies.
Although various factors contribute to the progression of atherosclerosis, immunological and inflammatory mechanisms may play an important role in proliferative arterial disease (11-13). Saireitoh is thought to have immunosuppressive and anti-inflammatory effects on the arterial walls. In this study, Saireitoh inhibited SMC proliferation in vitro. Although we expected that the effects of Saireitoh on vascular SMC proliferation and migration to help prevent the progression of atherosclerosis, Saireitoh did not prevent the development of atherosclerosis in our in vivo experiment.
A longer investigation may reveal an improvement in the anti-atherogenic effect.
During the course of this study, the body weights of rabbits in both the cholesterol and de-endothelial studies increased.
In the de-endothelial study, the decrease in plasma TC levels did not significantly affect the atherogenicity in either groups. Although Saireitoh did not have an effect on the plasma lipid levels, the balloon treatments may have influenced these results.
This study demonstrated that Saireitoh inhibits the proliferation of SMC and tends to suppress the development of atherosclerosis in the aorta and carotid arteries of NZW rabbits independent of the plasma lipid levels. Although further studies are necessary for understanding the effect of Kampo medicine on atherosclerosis, this study showed that Saireitoh tends to have an anti-atherogenic effect. 
